Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot simplification study of once-daily lopinavir/ritonavir monotherapy
2011-005981-39Phase 4Completed
- Sponsor
- Bellvitge University Hospital
- Start
- Jan 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of lopinavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by Bellvitge University Hospital. Primary endpoint: Virologic suppression at week 48. Started Jan 2012; status: completed.
02
Drugs
lopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2011-005981-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005981-39.